Thryv Therapeutics is a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.
Business Model:
Revenue: $0
Employees: 1-10
Address: 500 Boulevard Cartier Ouest
City: Laval
State: quebec
Zip: H7V 5B7
Country: CA
Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T waveQ and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated with unexpected and life-threatening ventricular arrhythmias. Click below to learn more about our programs.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2020 | Seed Round | 1 | $1.4M |
Fonds de solidarité FTQ Fonds de solidarité FTQ |
1/2020 | Seed | - | 6/2022 | Venture Round | $15M | 8/2021 | Series A | $0 |
Alexandria Venture Investments Amplitude Venture Capital Amzak Health Investors Fonds de solidarité FTQ Lumira Ventures Alexandria Venture Investments Amplitude Venture Capital Amzak Health Investors Fonds de solidarité FTQ Lumira Ventures |
8/2021 | Series A | 5 | $19M |
Amplitude Ventures Lumira Ventures Amzak Health Alexandria Venture Investments Fonds de solidarité FTQ Alexandria Venture Investments Amplitude Venture Capital Amzak Health Investors Fonds de solidarité FTQ Lumira Ventures |
1/2020 | Seed | - |
Fonds de solidarité FTQ Fonds de solidarité FTQ |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|